C4 Therapeutics, Inc.CCCCNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Above historical average.
Left:
||||
Price-to-book ratio
Latest
1.16
↑ 447% above average
Average (6y)
-0.33
Historical baseline
Range
High:5.08
Low:-9.79
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 1.16 | +1.5% |
| 2023 | 1.14 | +14.3% |
| 2022 | 1.00 | -73.8% |
| 2021 | 3.81 | -25.1% |
| 2020 | 5.08 | +151.9% |
| 2019 | -9.79 | -107.0% |
| 2018 | -4.73 | - |